Antimicrobial resistance and treatment: an unmet clinical safety need
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antimicrobial resistance and treatment: an unmet clinical safety need
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 17, Issue 7, Pages 669-680
Publisher
Informa UK Limited
Online
2018-06-14
DOI
10.1080/14740338.2018.1488962
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects
- (2018) Yutaka Saisho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015
- (2018) George G. Zhanel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2018) Ting-Ting Geng et al. MEDICINE
- Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam
- (2017) Marc Xipell et al. Future Microbiology
- Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
- (2017) Matthew Sims et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of the β-Lactamase Inhibitor Vaborbactam (RPX7009) in Healthy Adult Subjects
- (2016) David C. Griffith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation
- (2016) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
- (2016) Philippa C. Matthews et al. BMC INFECTIOUS DISEASES
- Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
- (2016) Florian M. Wagenlehner et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment
- (2016) Takayuki Katsube et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae
- (2016) Joshua T. Thaden et al. Virulence
- In VitroActivity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study
- (2015) Eliana S. Armstrong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
- (2015) Laura Honeyman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
- (2015) Joseph Solomkin et al. CLINICAL INFECTIOUS DISEASES
- New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections
- (2015) Matteo Bassetti et al. Current Opinion in Critical Care
- In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria
- (2015) Akinobu Ito et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- (2015) Florian M Wagenlehner et al. LANCET
- Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
- (2014) Kevin P. Connors et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bactericidal Activity, Absence of Serum Effect, and Time-Kill Kinetics of Ceftazidime-Avibactam against β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
- (2014) Tiffany R. Keepers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Eravacycline for the treatment of intra-abdominal infections
- (2014) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens
- (2014) Garyphallia Poulakou et al. Future Microbiology
- Siderophore–drug complexes: potential medicinal applications of the ‘Trojan horse’ strategy
- (2014) Agnieszka Górska et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012
- (2013) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoAntibacterial Activities of Omadacycline, a Novel Aminomethylcycline
- (2013) A. B. Macone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use
- (2013) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review
- (2013) Suzanne Parker et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
- (2013) Christopher Lucasti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
- (2012) Timothy P. Gauthier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unmet Medical Need in Infectious Diseases
- (2012) A. L. Hersh et al. CLINICAL INFECTIOUS DISEASES
- What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
- (2012) D. F. Florescu et al. CLINICAL INFECTIOUS DISEASES
- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
- (2012) Giulia Vicari et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
- (2011) J. M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli
- (2011) Fernando Docobo-Pérez et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Inhaled Anti-infective Agents: Emphasis on Colistin
- (2010) A. Michalopoulos et al. INFECTION
- Predictors of acute kidney injury associated with intravenous colistin treatment
- (2010) Jeong-Ah Kwon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Adverse events associated with intravenous fosfomycin
- (2010) Amélie Florent et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials
- (2010) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effectiveness and safety of colistin: prospective comparative cohort study
- (2010) Mical Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter Baumannii with aerosolized colistin in neonates: A preliminary report
- (2010) Narongsak Nakwan et al. PEDIATRIC PULMONOLOGY
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline
- (2009) April Barbour et al. CLINICAL PHARMACOKINETICS
- Multidrug-Resistant Gram-Negative Infections
- (2009) Helen Giamarellou et al. DRUGS
- Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates
- (2009) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2008) Alex P. Betrosian et al. JOURNAL OF INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search